Biocept Inc (BIOC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-MEDICAL LABORATORIES

9955 MESA RIM ROAD SAN DIEGO, CA 92121

Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers, including metastatic tumors involving lung, breast and the central nervous system. Biocept's patented Target Selectorâ„¢ technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) with higher sensitivity and specificity than most commercial assays. Additionally, Biocept is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 PCR testing to support public health efforts during this unprecedented pandemic.

Data as of 2021-10-17 09:54:57 -0400
Market Cap56.831 Million Shares Outstanding14.723 Million Avg 30-day Volume364.537 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.71 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.54819 52-week High/Low8.38 / 3.26 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -28.7038
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from BIOC instead.

View recent insider trading info

Funds Holding BIOC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIOC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NALL MICHAEL W. CEO & PRESIDENT

  • Officer
  • Director
180,000 2021-09-02 1

TERRY MICHAEL J SR VP OF BUSINESS DEVELOPMENT

  • Officer
35,000 2021-08-31 1

DUGAN MICHAEL C CHIEF MED OFF & MED. DIRECTOR

  • Officer
150,000 2021-08-31 1

KENNEDY TIMOTHY CFO, COO & SECRETARY

  • Officer
100,000 2021-08-31 1

HALE DAVID F

  • Director
10,000 2021-07-16 1

ROYSTON IVOR

  • Director
10,000 2021-07-16 1

WILSON MARGARET FAYE

  • Director
10,000 2021-07-16 1

RUBINSTEIN LINDA M

  • Director
0 2021-07-16 2

RICCITELLI SAMUEL D

  • Director
10,000 2021-07-16 1

GERHARDT BRUCE

  • Director
10,000 2021-07-16 1

CHANDLER MARSHA ALPERT

  • Director
10,000 2021-07-16 1

MORALES ANTONINO

  • Director
0 2021-07-16 2

HUEBNER BRUCE A

  • Director
0 2020-06-05 0

DUNN CORY SR. VP CORP. DEVELOPMENT

  • Officer
0 2020-03-30 0

ARNOLD LYLE J SR VP OF R&D AND CSO

  • Officer
0 2019-04-30 0

HENDRICK EDWIN SVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-04-30 0

ALLY BRIDGE LB HEALTHCARE MASTER FUND LTD

ALLY BRIDGE LB MANAGEMENT LTD

YU FAN

LI BIN

  • 10% Owner
3,147,667 2017-08-09 0

NEFF EDWARD A.

  • Director
0 2017-05-31 0

SINGH VEENA SR VP & SR MED DIRECTOR

  • Officer
53,333 2017-05-31 0

REISS CLAIRE

  • 10% Owner
No longer subject to file 2016-10-19 0

TRIVEDI RAAJ VP COMMERCIAL OPERATIONS

  • Officer
0 2016-02-29 0

FOLETTA MARK G INTERIM CFO

  • Officer
0 2015-08-31 0

KACHIOFF WILLIAM G SVP, CFO AND SECRETARY

  • Officer
0 2014-05-16 0

BISCHOFF FARIDEH Z. VICE PRESIDENT

  • Officer
0 2014-05-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NALL MICHAEL W. - Director - Officer CEO & PRESIDENT

2021-09-02 21:56:58 -0400 2021-09-02 A 80,000 a 80,000 direct

NALL MICHAEL W. - Director - Officer CEO & PRESIDENT

2021-09-02 21:56:58 -0400 2021-09-02 A 100,000 a 100,000 direct

KENNEDY TIMOTHY - Officer CFO, COO & SECRETARY

2021-09-02 21:21:48 -0400 2021-08-31 A 100,000 a 100,000 direct

TERRY MICHAEL J - Officer SR VP OF BUSINESS DEVELOPMENT

2021-09-02 21:23:43 -0400 2021-08-31 A 35,000 a 35,000 direct

DUGAN MICHAEL C - Officer CHIEF MED OFF & MED. DIRECTOR

2021-09-02 21:22:45 -0400 2021-08-31 A 150,000 a 150,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOCEPT INC BIOC 2021-10-22 22:15:03 UTC -3.5511 3.6211 95000
BIOCEPT INC BIOC 2021-10-22 21:45:03 UTC -3.78 3.85 95000
BIOCEPT INC BIOC 2021-10-22 21:15:03 UTC -3.78 3.85 95000
BIOCEPT INC BIOC 2021-10-22 20:45:03 UTC -3.6309 3.7009 95000
BIOCEPT INC BIOC 2021-10-22 20:15:03 UTC -3.6309 3.7009 95000
BIOCEPT INC BIOC 2021-10-22 19:45:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 19:15:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 18:45:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 18:15:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 17:45:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 17:15:03 UTC -3.6309 3.7009 100000
BIOCEPT INC BIOC 2021-10-22 16:45:03 UTC -3.6493 3.7193 100000
BIOCEPT INC BIOC 2021-10-22 16:15:04 UTC -3.6493 3.7193 100000
BIOCEPT INC BIOC 2021-10-22 15:45:03 UTC -3.6493 3.7193 100000
BIOCEPT INC BIOC 2021-10-22 15:15:03 UTC -3.6493 3.7193 100000
BIOCEPT INC BIOC 2021-10-22 14:45:03 UTC -3.5558 3.6258 95000
BIOCEPT INC BIOC 2021-10-22 14:15:03 UTC -3.5558 3.6258 90000
BIOCEPT INC BIOC 2021-10-22 13:45:03 UTC -3.5558 3.6258 90000
BIOCEPT INC BIOC 2021-10-22 13:15:03 UTC -3.5558 3.6258 95000
BIOCEPT INC BIOC 2021-10-22 12:45:03 UTC -3.5558 3.6258 90000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BIOC -4110.0 shares, $-17220.9 2021-06-30 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Biocept Inc 0.6% 2020-10-12 GERMANY

Elevate your investments